Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe

详细信息    查看全文

• 作者：Erica Salomone ; Tony Charman ; Helen McConachie…
• 关键词：Autism spectrum disorder ; Complementary and alternative medicine ; Europe ; Diets ; Supplements ; Mind–body practices
• 刊名：European Journal of Pediatrics
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：174
• 期：10
• 页码：1277-1285
• 全文大小：207 KB
• 参考文献：1.Akins RS, Krakowiak P, Angkustsiri K, Hertz-Picciotto I, Hansen RL (2014) Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. J Dev Behav Pediatr 35(1):1-0. doi:10.-097/?DBP.-000000000000013-/span> PubMed Central CrossRef PubMed
  2.Al Anbar NN, Dardennes RM, Prado-Netto A, Kaye K, Contejean Y (2010) Treatment choices in autism spectrum disorder: the role of parental illness perceptions. Res Dev Disabil 31(3):817-28. doi:10.-016/?j.?ridd.-010.-2.-07 CrossRef PubMed
  3.APA (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington
  4.Bernier R, Mao A, Yen J (2010) Psychopathology, families, and culture: autism. Child Adolesc Psychiatr Clin N Am 19(4):855-67. doi:10.-016/?j.?chc.-010.-7.-05 CrossRef PubMed
  5.Christon LM, Mackintosh VH, Myers BJ (2010) Use of complementary and alternative medicine (CAM) treatments by parents of children with autism spectrum disorders. Res Autism Spectr Disord 4(2):249-59. doi:10.-016/?j.?rasd.-009.-9.-13 CrossRef
  6.Davis TN, O’Reilly M, Kang S, Lang R, Rispoli M, Sigafoos J, Lancioni G, Copeland D, Attai S, Mulloy A (2013) Chelation treatment for autism spectrum disorders: a systematic review. Res Autism Spectr Disord 7(1):49-5. doi:10.-016/?j.?rasd.-012.-6.-05 CrossRef
  7.DeJong H, Bunton P, Hare D (2014) A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders. J Autism Dev Disord 44(9):2127-136. doi:10.-007/?s10803-014-2085-y CrossRef PubMed
  8.Elder J, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill L (2006) The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord 36(3):413-20. doi:10.-007/?s10803-006-0079-0 CrossRef PubMed
  9.Eurostat tSOotEU (2014) Tertiary educational attainment by sex, age group 30-4 (t2020_41). doi:http://?epp.?eurostat.?ec.?europa.?eu/?tgm/?table.?do??tab=?table&?init=-&?plugin=-&?language=?en&?pcode=?t2020_-1
  10.FDA (2014) U.S. Food and Drug Administration website: Beware of false or misleading claims for treating autism http://?www.?fda.?gov/?ForConsumers/?ConsumerUpdates/?ucm394757.?htm . Accessed 16/10/2014
  11.Goin-Kochel RP, Myers BJ, Mackintosh VH (2007) Parental reports on the use of treatments and therapies for children with autism spectrum disorders. Res Autism Spectr Disord 1(3):195-09. doi:10.-016/?j.?rasd.-006.-8.-06 CrossRef
  12.Granpeesheh D, Tarbox J, Dixon DR, Wilke AE, Allen MS, Bradstreet JJ (2010) Randomized trial of hyperbaric oxygen therapy for children with autism. Res Autism Spectr Disord 4(2):268-75. doi:10.-016/?j.?rasd.-009.-9.-14 CrossRef
  13.Green VA, Pituch KA, Itchon J, Choi A, O’Reilly M, Sigafoos J (2006) Internet survey of treatments used by parents of children with autism. Res Dev Disabil 27(1):70-4. doi:10.-016/?j.?ridd.-004.-2.-02 CrossRef PubMed
  14.Hall SE, Riccio CA (2012) Complementary and alternative treatment use for autism spectrum disorders. Complement Ther Clin Pract 18(3):159-63. doi:10.-016/?j.?ctcp.-012.-3.-04 CrossRef PubMed
  15.Hanson E, Kalish L, Bunce E, Curtis C, McDaniel S, Ware J, Petry J (2007) Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J Autism Dev Disord 37(4):628-36. doi:10.-007/?s10803-006-0192-0 CrossRef PubMed
  16.Holm M, Baird J, Kim Y, Rajora K, D’Silva D, Podolinsky L, Mazefsky C, Minshew N (2014) Therapeutic horseback riding outcomes of parent-identified goals for children with autism spectrum disorder: an ABA-multiple case design examining dosing and generalization to the home and community. J Autism Dev Disord 44(4):937-47. doi:10.-007/?s10803-013-1949-x PubMed Central CrossRef PubMed
  17.Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New YorkCrossRef
  18.James S, Montgomery P, Williams K (2011) Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 11
  19.Knivsberg AM, Reichelt KL, H?ien T, N?dland M (2002) A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 5(4):251-61. doi:10.-080/-028415029002894- CrossRef PubMed
  20.Levy SE, Hyman SL (2008) Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 17(4):803-20. doi:10.-016/?j.?chc.-008.-6.-04 PubMed Central CrossRef PubMed
  21.Levy SE, Mandell DS, Merhar S, Ittenbach RF, Pinto-Martin JA (2003) Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr 24(6):418-23CrossRef PubMed
  22.Liptak GS, Benzoni LB, Mruzek DW, Nolan KW, Thingvoll MA, Wade CM, Fryer GE (2008) Disparities in diagnosis and acce
• 作者单位：Erica Salomone (1)
  Tony Charman (1)
  Helen McConachie (2)
  Petra Warreyn (3)
  Working Group 4, COST Action ‘Enhancing the Scientific Study of Early Autism-/a>
  
  1. Department of Psychology, King’s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
  2. Institute of Health and Society, Newcastle University, Newcastle, UK
  3. Department of Experimental Clinical and Health Psychology, Ghent University, Ghent, Belgium
  
• 刊物主题：Pediatrics;
• 出版者：Springer Berlin Heidelberg
• ISSN：1432-1076

文摘

This study examined the prevalence and correlates of use of complementary and alternative medicine (CAM) among a sample of children with autism spectrum disorder (ASD)-lt;- years in 18 European countries (N--,680). Forty-seven percent of parents reported having tried any CAM approach in the past 6 months. Diets and supplements were used by 25 % of the sample and mind–body practices by 24 %; other unconventional approaches were used by 25 % of the families, and a minority of parents reported having tried any invasive or potentially harmful approach (2 %). Parents in Eastern Europe reported significantly higher rates of CAM use. In the total sample, children with lower verbal ability and children using prescribed medications were more likely to be receiving diets or supplements. Concurrent use of high levels of conventional psychosocial intervention was significantly associated with use of mind–body practices. Higher parental educational level also increased the likelihood of both use of diets and supplements and use of mind–body practices. Conclusion: The high prevalence of CAM use among a sample of young children with ASD is an indication that parents need to be supported in the choice of treatments early on in the assessment process, particularly in some parts of Europe. What is Known: -Use of complementary and alternative medicine (CAM) in children with autism spectrum disorder is common. -In non-EU samples, parents with higher educational level and parents of low functioning children are more likely to use CAM with their children. What is New: -This study provides the first data on prevalence and correlates of use of CAM approaches in a large sample of young children with autism in Europe (N--,680). -Rates of CAM use were particularly high in Eastern Europe and correlates of use varied by type of CAM across Europe.